tetano
Editor, Senior Moderator
J Biol Chem. 2015 Nov 11. pii: jbc.M115.693051. [Epub ahead of print]
[h=1]Molecular basis of mRNA cap recognition by Influenza B polymerase PB2 subunit.[/h] Xie L[SUP]1[/SUP], Wartchow C[SUP]1[/SUP], Shia S[SUP]1[/SUP], Uehara K[SUP]1[/SUP], Steffek M[SUP]1[/SUP], Warne R[SUP]1[/SUP], Sutton J[SUP]1[/SUP], Muiru GT[SUP]1[/SUP], Leonard VH[SUP]1[/SUP], Bussiere DE[SUP]1[/SUP], Ma X[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza virus polymerase catalyzes the transcription of viral mRNAs by a process known as 'cap-snatching', where the 5'-cap of cellular pre-mRNA is recognized by the PB2 subunit and cleaved 10-13 nucleotides downstream of the cap by the endonuclease PA subunit. Although this mechanism is common to both influenza A (FluA) and B (FluB) viruses, FluB PB2 recognizes a wider range of cap structures including m7GpppGm-, m7GpppG-, and GpppG-RNA, while FluA PB2 utilizes methylated G-capped RNA specifically. Biophysical studies with isolated PB2 cap-binding domain (PB2cap) confirm that FluB PB2 has expanded mRNA cap recognition capability although the affinities towards m7GTP are significantly reduced when compared to FluA PB2. The X-ray co-structures of the FluB PB2cap with bound cap analogs m7GTP and GTP reveal an inverted GTP binding mode that is distinct from the cognate m7GTP binding mode shared between FluA and FluB PB2. These results delineate the commonalities and differences in the cap-binding site between FluA and FluB PB2 and will aid structure-guided drug design efforts to identify dual inhibitors of both FluA and FluB PB2.
Copyright ? 2015, The American Society for Biochemistry and Molecular Biology.
[h=4]KEYWORDS:[/h] DSF; PB2; biophysics; cap-binding domain; crystal structure; influenza virus; isothermal titration calorimetry (ITC); ligand-binding protein; mRNA cap analog
PMID: 26559973 [PubMed - as supplied by publisher]
[h=1]Molecular basis of mRNA cap recognition by Influenza B polymerase PB2 subunit.[/h] Xie L[SUP]1[/SUP], Wartchow C[SUP]1[/SUP], Shia S[SUP]1[/SUP], Uehara K[SUP]1[/SUP], Steffek M[SUP]1[/SUP], Warne R[SUP]1[/SUP], Sutton J[SUP]1[/SUP], Muiru GT[SUP]1[/SUP], Leonard VH[SUP]1[/SUP], Bussiere DE[SUP]1[/SUP], Ma X[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza virus polymerase catalyzes the transcription of viral mRNAs by a process known as 'cap-snatching', where the 5'-cap of cellular pre-mRNA is recognized by the PB2 subunit and cleaved 10-13 nucleotides downstream of the cap by the endonuclease PA subunit. Although this mechanism is common to both influenza A (FluA) and B (FluB) viruses, FluB PB2 recognizes a wider range of cap structures including m7GpppGm-, m7GpppG-, and GpppG-RNA, while FluA PB2 utilizes methylated G-capped RNA specifically. Biophysical studies with isolated PB2 cap-binding domain (PB2cap) confirm that FluB PB2 has expanded mRNA cap recognition capability although the affinities towards m7GTP are significantly reduced when compared to FluA PB2. The X-ray co-structures of the FluB PB2cap with bound cap analogs m7GTP and GTP reveal an inverted GTP binding mode that is distinct from the cognate m7GTP binding mode shared between FluA and FluB PB2. These results delineate the commonalities and differences in the cap-binding site between FluA and FluB PB2 and will aid structure-guided drug design efforts to identify dual inhibitors of both FluA and FluB PB2.
Copyright ? 2015, The American Society for Biochemistry and Molecular Biology.
[h=4]KEYWORDS:[/h] DSF; PB2; biophysics; cap-binding domain; crystal structure; influenza virus; isothermal titration calorimetry (ITC); ligand-binding protein; mRNA cap analog
PMID: 26559973 [PubMed - as supplied by publisher]